Adnan Anjum, PureHealth’s chief commercial officer, and SEERS CEO Lee Young-shin (right) pose after signing an MOU at One Health’s booth during WHX Dubai 2026 in February. (Courtesy of SEERS)
Patients in the United Arab Emirates (UAE) could soon be tested for irregular heartbeats using wearable devices from Korean medical AI company SEERS, after the firm signed its first major Middle East contract.
SEERS said on Wednesday that it had agreed to supply at least 105,000 mobiCARE devices over three years to One Health, the medical device distribution arm of PureHealth, the UAE’s largest healthcare group.
The contract is worth about $14.7 million, according to the company. It follows a memorandum of understanding (MOU) signed between the two companies in February.
mobiCARE is a wearable heart-monitoring service. A patient wears the device for more than a day while it records the heart’s electrical activity, known as an electrocardiogram (ECG).
The data is then analyzed by AI to look for signs of arrhythmia, a condition in which the heart beats too fast, too slowly or irregularly. Doctors receive a report to help decide whether the patient needs further testing or treatment.
The device is already used in Korea by hospitals, clinics and health screening centers. More than 1,000 medical institutions in Korea had adopted mobiCARE by the end of 2025, with more than 620,000 tests carried out.
The UAE agreement gives SEERS access to a much larger healthcare network through PureHealth. One Health describes itself as a PureHealth subsidiary and a distributor of medical and diagnostic devices, while PureHealth says its portfolio includes hospitals, clinics, diagnostics, insurance, pharmacies and healthcare technology.
SEERS said it had received product approvals in Abu Dhabi and Dubai before signing the contract.
The company said demand in the Middle East and North Africa is being driven by rising rates of hypertension and cardiovascular disease, along with higher payment levels for diagnostic and monitoring services than in Korea.
It plans to use mobiCARE as an entry point to the region before expanding into thynC and home-based patient monitoring. thynC is a hospital ward monitoring system that uses wireless wearable devices to track admitted patients’ vital signs in real time.
SEERS said proof-of-concept work for thynC had already been completed at Sheikh Shakhbout Medical City in Abu Dhabi, which PureHealth describes as the UAE’s largest healthcare complex.
Kim Ji-hye
댓글
0